Prostaglandin E1 reduces thromboxane A2 in hepatic ischemia-reperfusion

Hepato-Gastroenterology

Volumn 47, Issue 33, 2000, Pages 807-811

  Hanazaki, Kazuhiro ^a   Kuroda, Takai ^a   Kajikawa, Shoji ^a   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

6 ketoprostaglandin F(1 ); Ischemia reperfusion injury; Lipid peroxide; Prostaglandin E1; Thromboxane B2

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIPID PEROXIDE; PROSTACYCLIN; PROSTAGLANDIN E1; THROMBOXANE A2; SCAVENGER; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; LIVER ISCHEMIA; LIVER PERFUSION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; BIOSYNTHESIS; BLOOD; DOG; DRUG EFFECT; LIPID PEROXIDATION; LIVER; PATHOPHYSIOLOGY; VASCULARIZATION;

ALPROSTADIL; ANIMALS; DOGS; EPOPROSTENOL; FREE RADICAL SCAVENGERS; LIPID PEROXIDATION; LIVER; REPERFUSION INJURY; THROMBOXANE A2; VASODILATOR AGENTS;

EID: 0033623716     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. 1 Dusting GJ, Moncada S, Vane JR: Prostacyclin (PGX) is the endogenous metabolite of arachidonic acid which relaxes coronary arteries. Prostaglandins 1977; 12:3-15.
2. 2 Higgs EA, Higgs GA, Moncada S, Vane JR: Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. Br J Pharmacol 1978; 63:535-539.
3. 3 Moncada S, Gryglewski R, Bunting S, Vane JR: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263:663-665.
4. 4 Lefer AM, Ogletree ML, Smith JB, Silver MJ, Nicolaou KC, Barnette WE, Gasic GP: Prostacyclin: A potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science 1978; 200:52-54.
5. 5 Foegh ML, Winchester JF, Zmudka M, Helfrich GB, Cooley C, Ramwell PW, Schreiner GE: Urine i-TXB2 in renal allograft rejection. Lancet 1981; 318:431-434.
6. 6 Hanazaki K, Kuroda T, Haha Y, Shiohara E, Kajikawa S, Iida F: Protective effect of the thromboxane A2 receptor antagonist ONO 3708 on ischemia-reperfusion injury in the dog liver. Surgery 1994; 116:896-903.
7. 7 Shimada M, Matsumata T, Shirabe K, Sugimachi K: A thromboxane A2 synthetase inhibitor, ONKY-046, reduces liver damage in hepatectomy. Surgery 1993; 114:993-995.
8. 8 Shirabe K, Kin S, Shinagawa Y, Chen S, Payne WD, Sugimachi K: Inhibition of thromboxane A2 activity during warm ischemia of the liver. J Surg Res 1996; 61:103-107.
9. 9 Hanazaki K, Kuroda T, Kajikawa S, Miyamoto H, Iida F: Protective effects of Coenzyme Q10 on the metabolism of prostglandin I2 and thromboxane A2 in the warm ischemic liver. Res Surg 1993; 5:112-116.
10. 10 Besse T, Gustin N, Claeys N, Schroeyers P, Lambotte L: Effect of PGI2 and thromboxane antagonist on liver ischemic injury. Eur Surg Res 1989; 21:213-217.
11. 11 Hanazaki K, Kuroda T, Kajikawa S, Shiohara E, Haba Y, Iida F: Prostaglandin E1 protects liver from ischemic damage. J Surg Res 1994; 57:380-384.
12. 12 Totsuka E, Sasaki M, Takahashi K, Toyoki Y, Seino K, Hakamada K, Konn M: The effect of intraportal PGE1 on warm ischemic liver damage. Surg Today 1994; 24:1028-1030.
13. 13 Helling TS, Hacker KA, Kragel PJ, Einstein CL: Evidence for cytoprotection by prostaglandin E1 with normothermic hepatic ischemia. J Surg Res 1994; 56:309-313.
14. 14 Grafa F, Gugenheim J, Saint-Paul MC, Cavanel C, Laparus F, Ouzan D, Militerno G, Mouiel J: Protective effects of prostaglandin E1 on normothermic liver ischemia. Eur Surg Res 1991; 23:278-282.
15. 15 Pringle JH: Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908; 48:541-549.
16. 16 Powell WS: Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 1980; 20:947-957.
17. 17 Yagi K: A simple fluorometric assay for lipid peroxidase in blood plasma. Biochem Med 1976; 15:212-216.
18. 18 Fabia R, Travis DL, Levy MF, Husberg BoS, Goldstein RM, Klintmalm GB: Effect of pentoxifylline on hepatic ischemia and reperfusion injury. Surgery 1997; 121:520-525.
19. 19 Shirabe K, Takenaka K, Yamamoto K, Kitamura M, Itasaka H, Matsumata T, Shimada M, Sugimachi K. The role of prostanoid in hepatic damage during hepatectomy. Hepatogastroenterology 1996; 43:596-601.
20. 20 Tanabe G, Aikou T, Kurita K, Kobayashi Y, Ueno S, Mitue S, Hamanoue M, Kawaida K, Ogura Y, Yoshidome S: Effects of exogenous prostaglandin E1 in hepatectomized patients. J Hepatobiliary Pancreat Surg 1994; 4:402-405.
21. 21 Masaki N, Ohta Y, Shirataki H, Ogata I, Hayashi S, Yamada S, Hirata K, Nagoshi S, Mochida S, Tomiya T, Ohno A, Ohta Y, Fujiwara K: Hepatocyte membrane stabilization by prostaglandin E1 and E2: Favorable effects on rat liver injury. Gastroenterology 1992; 102:572-576.
22. 22 Ajima H, Miyata M, Nishimaki T, Kasukawa R, Ito M: Effects of prostaglandins on O2-production of human polymorphonuclear leukocytes. Jpn J Inf 1985; 5:125-129.
23. 23 Sha'afi RI, Naccahe PH, Alobidi T, Molski TFP, Volpi M: Effect of arachidonic acid and the chemotactic factor F-Met-Leu-Phe on cation transport in rabbit neutrophils. J Cell Physiol 1981; 106:215-223.
24. 24 Smolen JE, Korchak HM, Wiesmann G: Increased levels of cyclic adenosine-3',5'-monophosphate in human polymorphonuclear leukocytes after surface stimulation. J Clin Invest 1980; 65:1077-1085.
25. 25 Someya A, Nagaoka I, Ishibashi Y, Hora E, Yamashita T: Effect of prostaglandins on Superoxide generation of guineapig neutrophil induced by soluble stimuli. Jpn J Inf 1984; 4:112-115.
26. 26 McCord JM: Oxygen derived free radicals in post-ischemic tissue injury. N Engl J Med 1985; 312:159-163.
27. 27 Teraoka S, Takahashi K, Toma H, Yagisawa T, Yamaguchi Y, Sanaka T, Fuchinoue S, Honda H, Kawai T, Tanabe K, Yasuo M, Hayasaka Y, Agishi T, Ota K: New approach to management of chronic vascular rejection with prostacyclin analogue after kidney transplantation. Transplant Proc 1987; 19:2115-2119.
28. 28 Johnson BF, Webster MJ, Wiley KN, Herold A, Fox M, Raftery AT: Urinary amylase and immunoreactive metabolites of thromboxane B2 and 6-ketoPGF1 alpha in rat pancreatic allograft rejection. Transplant Proc 1989; 21:2788-2790.
29. 29 Garcia-Valdecasas JC, Cugat E, Almenara R, Grande L, Angas J, Fuster J, Visa J: Ischemia-reperfusion injury in an ischemic rat liver model: Relationship between oxygen-derived free radicals and prostaglandin. Transplant Proc 1990; 22:523-526.
30. 30 Ham EA, Egan RW, Soderman DD, Gale PH, Kuehl Jr FA: Peroxide-dependent deactivation of prostacyclin synthetase. J Biol Chem 1979; 254:2191-2194.
31. 31 Kuroda T, Shiohara E, Haba Y, Hanazaki K, Homma T, Iwatsuki K, Chiba S: Prostaglandin E1 protects dog pancreas from ischemia-reperfusion injury. Pancreas 1994; 9:354-360.
32. 32 Isai H, Sheil AGR, McCaughan G, Dolan P, Nargh RV: Successful reversal of primary graft non-function in a liver transplant patient treated with prostaglandin E1. Aust NZL Surg 1992; 62:314-316.
33. 33 Tancharoen S, Jones RM, Angus PW, Michell ID, Nicolf Mc, Hardy KJ: Prostaglandin E1 therapy in orthotopic liver transplantation recipients: indications and outcome. Transplant Proc 1992; 24:2248-2249.
34. 34 Greig PD, Woolf GM, Sinclair SB, Abecassis M, Strasberg SM, Taylor BR, Blendis LM, Superina RA, Glynn MFX, Langer B, Levy GA: Treatment of primary liver graft non-function with prostaglandin E1. Transplantation 1989; 48:447-453.